Lewis Asset Management LLC Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lewis Asset Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,757 shares of the medical equipment provider’s stock, valued at approximately $593,000.

Other large investors have also bought and sold shares of the company. Portside Wealth Group LLC raised its holdings in Intuitive Surgical by 8.2% in the fourth quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 62 shares during the period. Blair William & Co. IL raised its holdings in Intuitive Surgical by 3.1% in the third quarter. Blair William & Co. IL now owns 377,371 shares of the medical equipment provider’s stock worth $110,302,000 after purchasing an additional 11,400 shares during the period. Assenagon Asset Management S.A. raised its holdings in Intuitive Surgical by 21.2% in the third quarter. Assenagon Asset Management S.A. now owns 739,471 shares of the medical equipment provider’s stock worth $216,140,000 after purchasing an additional 129,194 shares during the period. Falcon Wealth Planning acquired a new stake in Intuitive Surgical in the fourth quarter worth $2,084,000. Finally, AMF Tjanstepension AB raised its holdings in shares of Intuitive Surgical by 637.3% during the third quarter. AMF Tjanstepension AB now owns 127,624 shares of the medical equipment provider’s stock worth $37,303,000 after acquiring an additional 110,314 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 24,325 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $376.06, for a total value of $9,147,659.50. Following the completion of the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at approximately $3,544,365.50. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary S. Guthart sold 24,325 shares of the company’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $376.06, for a total transaction of $9,147,659.50. Following the sale, the chief executive officer now owns 9,425 shares of the company’s stock, valued at $3,544,365.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 248,418 shares of company stock valued at $95,927,097. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 1.2 %

NASDAQ ISRG opened at $378.92 on Friday. The company’s 50 day moving average is $387.16 and its 200-day moving average is $336.29. The firm has a market cap of $134.31 billion, a P/E ratio of 75.33, a price-to-earnings-growth ratio of 5.95 and a beta of 1.36. Intuitive Surgical, Inc. has a 12-month low of $252.04 and a 12-month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, beating the consensus estimate of $1.48 by $0.12. The company had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. Intuitive Surgical’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.91 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Barclays raised their price objective on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Mizuho raised their target price on shares of Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Finally, Truist Financial raised their target price on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $375.20.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.